Roper Industries, Inc. Q1 2013 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2013. Roper Industries, Inc. is a diversified growth company operating in four segments: Industrial Technology, Energy Systems & Controls, Medical & Scientific Imaging, and RF Technology. The company designs, manufactures, and distributes products and software for markets including medical, water, energy, research, and security.
Key Financial Metrics
| Metric | Q1 2013 | Q1 2012 |
|---|---|---|
| Net Sales | $737.1 million | $711.1 million |
| Gross Profit | $421.6 million | $391.2 million |
| Gross Margin | 57.2% | 55.0% |
| Operating Income | $185.2 million | $170.3 million |
| Net Earnings | $124.9 million | $108.3 million |
| Diluted EPS | $1.25 | $1.09 |
| Operating Cash Flow | $171.3 million | $141.5 million |
| Total Debt | $1.92 billion | $2.02 billion (Dec 2012) |
| Cash & Equivalents | $430.0 million | $370.6 million (Dec 2012) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 3.7% year-over-year, driven by a 7% contribution from acquisitions, partially offset by a 3% decline in organic growth.
- Segment Performance:
- Medical & Scientific Imaging: Sales surged 23.1% and operating profit rose 38.2%, driven by 2012 acquisitions and higher-margin medical products.
- RF Technology: Sales grew 2.1% with operating profit up 12.5% due to growth in toll/traffic and security solutions.
- Industrial Technology: Sales declined 6.6% due to the loss of a water metering customer and lower materials testing sales.
- Energy Systems & Controls: Sales decreased 2.0% due to lower industrial pressure sensor sales.
- Expenses: Interest expense increased to $20.9 million (from $15.5 million) due to higher debt balances from 2012 acquisitions. Corporate expenses rose to $20.0 million, largely due to increased stock-based compensation.
- Tax Rate: The effective tax rate dropped to 22.8% from 29.8%, aided by $12 million in discrete tax benefits related to the American Taxpayer Relief Act of 2012.
- Currency Impact: Foreign currency translation adjustments resulted in a $38.5 million reduction in comprehensive income due to weaker European and Canadian currencies against the U.S. dollar.
Outlook, Risks, and Unusual Items
- Subsequent Event: On May 1, 2013, Roper acquired Managed Health Care Associates, Inc. (MHA) for $1.0 billion in an all-cash transaction.
- Orders and Backlog: Net orders increased 9% to $793.6 million. Order backlog rose 17% to $996.9 million.
- Debt Reduction: Management anticipates using operating cash flows to reduce outstanding debt, though the rate depends on future acquisitions and performance.
- Risks: Key risks include geopolitical uncertainties, integration of acquired businesses, foreign exchange fluctuations, and potential write-offs of substantial goodwill and intangible assets.
- Legal: The company faces routine product liability and employment litigation, as well as asbestos-related claims, though management believes provisions are adequate and no material adverse effect is expected.
Investor Verification Checklist
- Acquisition Integration: Verify the integration progress and financial contribution of 2012 acquisitions, which drove significant revenue growth in the Medical segment.
- Organic Growth Trends: Monitor the negative organic growth (-3%) reported in Q1 to assess if it is a temporary anomaly or a structural shift.
- Debt Servicing: Review the impact of the $1.92 billion debt load on future interest expenses and cash flow availability.
- Foreign Exchange Exposure: Assess the sensitivity of future earnings to currency fluctuations given the significant translation loss in Q1.
- Subsequent Acquisition: Evaluate the strategic fit and financial impact of the $1.0 billion MHA acquisition announced post-period.